Takeda is entering one of the most pivotal moments in its 245-year history, with a late-stage pipeline poised to transform patient outcomes across three therapeutic areas. Chief Scientific Officer Chris Arendt goes Inside the ICE House to discuss the science behind drug candidates targeting narcolepsy, polycythemia vera, and psoriasis. He explores how AI and computational technologies are reshaping drug discovery and why building the right data foundation is critical to supercharging Takeda's R&D engine.

ETF Central: MarketGrader Founder & CEO Carlos Diez

Inside the ICE House, a podcast produced by Intercontinental Exchange, takes listeners behind the historic façade of the New York Stock Exchange and inside the global financial marketplace. The episodes, recorded in the Library of the NYSE, features conversations with leaders, entrepreneurs and visionaries who walk through our doors with a dream of building businesses and changing the world. Their stories have made the NYSE, now part of ICE’s ecosystem of markets, clearing houses, data provider, and listings services, an indispensable institution for over 225 years.